Dipeptidyl peptidase IV inhibition upregulates GLUT4 translocation and expression in heart and skeletal muscle of spontaneously hypertensive rats

European Journal of Pharmacology

Volumn 698, Issue 1-3, 2013, Pages 74-86

  Giannocco, Gisele ^a,b   Oliveira, Kelen C ^a,b   Crajoinas, Renato O ^c   Venturini, Gabriela ^c   Salles, Thiago A ^c   Fonseca Alaniz, Miriam H ^c   MacIel, Rui M B ^b   Girardi, Adriana C C ^c  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dipeptidyl peptidase IV; Glucagon like peptide 1; Glucose transporter type 4; Heart; Hypertension; Skeletal muscle

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; GLUCAGON LIKE PEPTIDE 1; GLUCOSE TRANSPORTER 4; MESSENGER RNA; SITAGLIPTIN;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME SUBSTRATE; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; GLUT4 GENE; HEART; HEART MUSCLE CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; UPREGULATION; WISTAR KYOTO RAT;

ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HEART; HOMEOSTASIS; INTRACELLULAR SPACE; MALE; MUSCLE, SKELETAL; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN TRANSPORT; PYRAZINES; RATS; RATS, INBRED SHR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRIAZOLES; UP-REGULATION;

EID: 84871927685     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.09.043     Document Type: Article

References (40)

1. B. Ahren Gut peptides and type 2 diabetes mellitus treatment Curr. Diab. Rep. 3 2003 365 372 (Pubitemid 38906794)
2. M.L. Barreto-Chaves, A. Heimann, and J.E. Krieger Stimulatory effect of dexamethasone on angiotensin-converting enzyme in neonatal rat cardiac myocytes Braz. J. Med. Biol. Res. 33 2000 661 664 (Pubitemid 30428608)
3. I. Brandt, A.M. Lambeir, J.M. Ketelslegers, M. Vanderheyden, S. Scharpe, and I. De Meester Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form Clin. Chem. 52 2006 82 87 (Pubitemid 43032470)
4. T.A. Buchanan, J.H. Youn, V.M. Campese, and G.F. Sipos Enhanced glucose tolerance in spontaneously hypertensive rats. Pancreatic beta-cell hyperfunction with normal insulin sensitivity Diabetes 41 1992 872 878
5. I.W. Campbell, A.F. Dominiczak, C. Livingstone, and G.W. Gould Analysis of the glucose transporter compliment of metabolically important tissues from the Milan hypertensive rat Biochem. Biophys. Res. Commun. 211 1995 780 791
6. C. Chen, H. Hosokawa, L.M. Bumbalo, and J.L. Leahy Mechanism of compensatory hyperinsulinemia in normoglycemic insulin-resistant spontaneously hypertensive rats. Augmented enzymatic activity of glucokinase in beta-cells J. Clin. Invest. 94 1994 399 404
7. G.E. Chiappe De Cingolani, and C.I. Caldiz Insulin resistance and GLUT-4 glucose transporter in adipocytes from hypertensive rats Metabolism 53 2004 382 387 (Pubitemid 38684700)
8. S.L. Conarello, Z. Li, J. Ronan, R.S. Roy, L. Zhu, G. Jiang, F. Liu, J. Woods, E. Zycband, D.E. Moller, N.A. Thornberry, and B.B. Zhang Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance Proc. Nat. Acad. Sci. U.S.A. 100 2003 6825 6830 (Pubitemid 36666664)
9. R.O. Crajoinas, L.M. Lessa, L.R. Carraro-Lacroix, A.P. Davel, B.P. Pacheco, L.V. Rossoni, G. Malnic, and A.C. Girardi Posttranslational mechanisms associated with reduced NHE3 activity in adult vs. young prehypertensive SHR Am. J. Physiol. Renal. Physiol. 299 2010 F872 881
10. S.Y. Ding, A. Nkobena, C.A. Kraft, M.L. Markwardt, and M.A. Rizzo Glucagon-like peptide 1 stimulates post-translational activation of glucokinase in pancreatic beta cells J. Biol. Chem. 286 2001 16768 16774
11. D.J. Drucker Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes Expert Opin. Investig. Drugs 12 2003 87 100 (Pubitemid 36104645)
12. D.J. Drucker, and M.A. Nauck The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 368 2006 1696 1705 (Pubitemid 46048557)
13. A.C. Girardi, and F. Di Sole Deciphering the mechanisms of the Na+/H+ exchanger-3 regulation in organ dysfunction Am. J. Physiol. Cell. Physiol. 302 2012 C1569 1587
14. M. Gronborg, T.Z. Kristiansen, A. Stensballe, J.S. Andersen, O. Ohara, M. Mann, O.N. Jensen, and A. Pandey A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate Mol. Cell. Proteomics 1 2002 517 527
15. J.J. Holst The physiology of glucagon-like peptide 1 Physiol. Rev. 87 2007 1409 1439 (Pubitemid 350041474)
16. E.K. Jackson, and Z. Mi Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension Hypertension 51 2008 1637 1642
17. D.E. James, R. Brown, J. Navarro, and P.F. Pilch Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein Nature 333 1988 183 185
18. D.E. James, A.B. Jenkins, and E.W. Kraegen Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats Am. J. Physiol. 248 1985 E567 574
19. S. Katayama, M. Abe, H. Kashiwabara, I. Kosegawa, and J. Ishii Evidence against a role of insulin in hypertension in spontaneously hypertensive rats. CS-045 does not lower blood pressure despite improvement of insulin resistance Hypertension 23 1994 1071 1074 (Pubitemid 24180869)
20. S. Katayama, M. Inaba, Y. Maruno, T. Morita, T. Awata, and Y. Oka Glucose intolerance in spontaneously hypertensive and Wistar-Kyoto rats: enhanced gene expression and synthesis of skeletal muscle glucose transporter 4 Hypertens. Res. 20 1997 279 286
21. A.M. Lambeir, C. Durinx, S. Scharpe, and I. De Meester Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV Crit. Rev. Clin. Lab. Sci. 40 2003 209 294 (Pubitemid 36775376)
22. H.P. Lauritzen, and J.D. Schertzer Measuring GLUT4 translocation in mature muscle fibers Am. J. Physiol. Endocrinol. Metab. 299 2010 E169 179
23. M.K. Lee, P.D. Miles, M. Khoursheed, K.M. Gao, A.R. Moossa, and J.M. Olefsky Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat Diabetes 43 1994 1435 1439
24. A.M. Lehnen, N.M. Leguisamo, G.H. Pinto, M. Markoski, K. De Angelis, U.F. Machado, and B. Schaan Exercise-stimulated GLUT4 expression is similar in normotensive and hypertensive rats Horm. Metab. Res. 43 2011 231 235
25. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
26. D. Marguet, L. Baggio, T. Kobayashi, A.M. Bernard, M. Pierres, P.F. Nielsen, U. Ribel, T. Watanabe, D.J. Drucker, and N. Wagtmann Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26 Proc. Nat. Acad. Sci. U.S.A. 97 2000 6874 6879 (Pubitemid 30412807)
27. R. Mentlein, P. Dahms, D. Grandt, and R. Kruger Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV Regul. Pept. 49 1993 133 144
28. R. Mentlein, B. Gallwitz, and W.E. Schmidt Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36) amide, peptide histidine methionine and is responsible for their degradation in human serum Eur. J. Biochem. 214 1993 829 835 (Pubitemid 23188160)
29. G.C. Mistry, A.L. Maes, K.C. Lasseter, M.J. Davies, K.M. Gottesdiener, J.A. Wagner, and G.A. Herman Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension J. Clin. Pharmacol. 48 2008 592 598 (Pubitemid 351503521)
30. T. Okerson, P. Yan, A. Stonehouse, and R. Brodows Effects of exenatide on systolic blood pressure in subjects with type 2 diabetes Am. J. Hypertens. 23 2011 334 339
31. B.P. Pacheco, R.O. Crajoinas, G.K. Couto, A.P. Davel, L.M. Lessa, L.V. Rossoni, and A.C. Girardi Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats J. Hypertens. 29 2011 520 528
32. F.E. Palmieri, and P.E. Ward Mesentery vascular metabolism of substance P Biochim. Biophys. Acta 755 1983 522 525 (Pubitemid 13146761)
33. G. Paternostro, K. Clarke, J. Heath, A.M. Seymour, and G.K. Radda Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart Cardiovasc. Res. 30 1995 205 211
34. G.M. Reaven, H. Chang, B.B. Hoffman, and S. Azhar Resistance to insulin-stimulated glucose uptake in adipocytes isolated from spontaneously hypertensive rats Diabetes 38 1989 1155 1160 (Pubitemid 19250402)
35. T. Shioda, H. Kato, Y. Ohnishi, K. Tashiro, M. Ikegawa, E.E. Nakayama, H. Hu, A. Kato, Y. Sakai, H. Liu, T. Honjo, A. Nomoto, A. Iwamoto, C. Morimoto, and Y. Nagai Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage Proc. Nat. Acad. Sci. U.S.A. 95 1998 6331 6336 (Pubitemid 28249012)
36. T. Tanaka, M. Nangaku, and A. Nishiyama The role of incretins in salt-sensitive hypertension: the potential use of dipeptidyl peptidase-IV inhibitors Curr. Opin. Nephrol. Hypertens. 20 2011 476 481
37. B. Thorens, M.J. Charron, and H.F. Lodish Molecular physiology of glucose transporters Diabetes Care. 13 1990 209 218 (Pubitemid 20092108)
38. M.L. Villanueva-Penacarrillo, J. Puente, A. Redondo, F. Clemente, and I. Valverde Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models Endocrine 15 2001 241 248 (Pubitemid 32977337)
39. A.K. Vyas, K.C. Yang, D. Woo, A. Tzekov, A. Kovacs, P.Y. Jay, and P.W. Hruz Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy PLoS One 6 2011 e17178
40. S. Yoshioka, H. Nishino, T. Shiraki, K. Ikeda, H. Koike, A. Okuno, M. Wada, T. Fujiwara, and H. Horikoshi Antihypertensive effects of CS-045 treatment in obese Zucker rats Metabolism 42 1993 75 80 (Pubitemid 23019936)